WHO WE ARE
NanoGenics is the leading company developing the artificial virus, a new kind of vector for gene therapy.
We have committed to overcoming the obstacle of delivery to fulfil the promise of gene therapy, working alongside innovative partners to bring cutting-edge treatments to market.
Read more about who we are...
WHAT WE DO
Introducing LipTide: The artificial virus
LipTide is a revolutionary nanoscale delivery vehicle invented to mimic a natural virus for targeted delivery of all forms DNA and RNA into cells.
With appealing clinical properties and the capability to deliver genetic material to almost any cell type, LipTide can help realise the potential of your gene therapy.
Read more about what we do...
Working with you
Every component of LipTide can be customised for purpose, offering unprecedented flexibility in target and payload.
Together, we can develop a bespoke research plan and create a LipTide solution to get your gene therapy from pipeline to patient.
Read more about working with you...
therapy treatments using LipTide are already in development in-house at NanoGenics.
An inhaled treatment
for cystic fibrosis
tumour growth suppressor
A novel glaucoma
INVESTING IN US
Animal studies have suggested amyotrophic lateral sclerosis #ALS can be prevented with #GeneTherapy - but delivery… https://t.co/WJEl1Uab8r
Current #GeneTherapy solutions are held back by toxicity which makes repeat dosing unsafe. Our delivery system is t… https://t.co/oxRVCY8Ysb
Researchers inspired by a young patient with an inherited cardiac arrhythmia disorder are now looking for a… https://t.co/n6Z3pXVVkM